Although HSP-peptide complex-based vaccines appear promising for pancreatic cancer patients, Maki et al. have demonstrated it can be challenging to yield enough HSP peptide complex-based vaccine preparations from resected tumours specimens [118]. The gene discussed is HSP90B2P; the disease is familial pancreatic carcinoma.